Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anika Therapeutics Inc (NASDAQ:ANIK)

44.70
Delayed Data
As of May 03
 -0.87 / -1.91%
Today’s Change
30.93
Today|||52-Week Range
49.25
+17.14%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$673.0M

Company Description

Anika Therapeutics, Inc. is global medical technology company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration and wound healing. The company's products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical and veterinary. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Contact Information

Anika Therapeutics, Inc.
32 Wiggins Avenue
Bedford Massachusetts 01730
P:(781) 457-9000
Investor Relations:
(781) 305-9713

Employees

Shareholders

Other institutional59.00%
Mutual fund holders34.79%
Individual stakeholders15.27%

Top Executives

Charles H. SherwoodPresident, Chief Executive Officer & Director
Dana M. AlexanderChief Operating Officer
Sylvia CheungChief Financial Officer & Head-Investor Relations
Carol PekarVice President-Regulatory & Clinical Affairs
Edward S. AhnChief Technology & Strategy Officer